Description de l'entreprise
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app.
Conseil d'administration & Conseil de surveillance
| PDG |
| Christopher Simon |
| Conseil d'administration |
| James C. D'Arecca, Michelle L. Basil, Kerri DiPietro, Roy Galvin, Jan Hartmann, Anila Lingamneni, Josep Lluis Llorens, Laurie Miller, Stewart W. Strong, Rajeev Varma |
| Conseil de surveillance |
| Ellen M. Zane, Christopher A. Simon, Robert E. Abernathy, Diane M. Bryant, Michael J. Coyle, Charles J. Dockendorff, Lloyd E. Johnson, Mark W. Kroll, Claire Pomeroy |
Données de l'entreprise
| Nom: |
Haemonetics Corporation |
| Adresse: |
125 Summer Street,Boston, MA 02110, USA |
| Téléphone: |
+1-781-848-7100 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.haemonetics.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/03 |
| Flotte libre: |
99.06% |
| IPO date: |
- |
